Advertisement
ACIU vs ALEC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Hold and ALEC is a Buy.
ACIU in upward trend: price may jump up because it broke its lower Bollinger Band on October 26, 2026
ACIU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 37 cases where ACIU's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 66 cases where ACIU's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
Following a +4.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACIU advanced for three days, in 171 of 230 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACIU as a result. In 72 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
ACIU moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ACIU crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACIU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for ACIU entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.700) is normal, around the industry mean (3.070). P/E Ratio (-5.512) is within average values for comparable stocks, (-1.257). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.491) among similar stocks. P/S Ratio (12.547) is also within normal values, averaging (439.237).
The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. ACIU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACIU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
ALEC sees its 50-day moving average cross bullishly above its 200-day moving average
The 50-day moving average for ALEC moved above the 200-day moving average on September 28, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on ALEC as a result. In 82 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for ALEC just turned positive on October 27, 2026. Looking at past instances where ALEC's MACD turned positive, the stock continued to rise in 33 of 39 cases over the following month. The odds of a continued upward trend are 85%.
ALEC moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +22.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALEC advanced for three days, in 220 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for ALEC crossed bearishly below the 50-day moving average on September 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALEC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
ALEC broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ALEC entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-25.086) is normal, around the industry mean (3.070). P/E Ratio (-2.055) is within average values for comparable stocks, (-1.257). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.491) among similar stocks. P/S Ratio (15.060) is also within normal values, averaging (439.237).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. ALEC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALEC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
ACIU | ALEC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 59 | 46 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 67 Overvalued | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 73 | 37 | |
P/E GROWTH RATING 1..100 | 49 | 92 | |
SEASONALITY SCORE 1..100 | 50 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ALEC's Valuation (6) in the Biotechnology industry is somewhat better than the same rating for ACIU (67) in the Pharmaceuticals Major industry. This means that ALEC’s stock grew somewhat faster than ACIU’s over the last 12 months.
ALEC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ACIU (100) in the Pharmaceuticals Major industry. This means that ALEC’s stock grew similarly to ACIU’s over the last 12 months.
ACIU's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as ALEC (100) in the Biotechnology industry. This means that ACIU’s stock grew similarly to ALEC’s over the last 12 months.
ALEC's Price Growth Rating (37) in the Biotechnology industry is somewhat better than the same rating for ACIU (73) in the Pharmaceuticals Major industry. This means that ALEC’s stock grew somewhat faster than ACIU’s over the last 12 months.
ACIU's P/E Growth Rating (49) in the Pharmaceuticals Major industry is somewhat better than the same rating for ALEC (92) in the Biotechnology industry. This means that ACIU’s stock grew somewhat faster than ALEC’s over the last 12 months.
| ACIU | ALEC | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 89% |
| Momentum ODDS (%) | 2 days ago 88% | 2 days ago 84% |
| MACD ODDS (%) | N/A | 2 days ago 85% |
| TrendWeek ODDS (%) | 2 days ago 86% | 2 days ago 83% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 80% |
| Advances ODDS (%) | 11 days ago 74% | 3 days ago 84% |
| Declines ODDS (%) | 4 days ago 85% | 9 days ago 86% |
| BollingerBands ODDS (%) | 2 days ago 89% | 2 days ago 84% |
| Aroon ODDS (%) | 2 days ago 83% | 2 days ago 81% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ACIU’s FA Score shows that 0 FA rating(s) are green while ALEC’s FA Score has 1 green FA rating(s).
- ACIU’s FA Score: 0 green, 5 red.
- ALEC’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ACIU’s TA Score shows that 3 TA indicator(s) are bullish while ALEC’s TA Score has 5 bullish TA indicator(s).
- ACIU’s TA Score: 3 bullish, 5 bearish.
- ALEC’s TA Score: 5 bullish, 5 bearish.
Price Growth
ACIU (@Biotechnology) experienced а -5.20% price change this week, while ALEC (@Biotechnology) price change was +22.40% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +6.09%. For the same industry, the average monthly price growth was -10.58%, and the average quarterly price growth was -13.79%.
Reported Earning Dates
ACIU is expected to report earnings on Nov 03, 2026.
ALEC is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Biotechnology (+6.09% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ACIU and
Correlation & Price change
A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with KYTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then KYTX could also see price increases.
| Ticker / NAME | Correlation To ACIU | 1D Price Change % | ||
|---|---|---|---|---|
| ACIU | 100% | N/A | ||
| KYTX - ACIU | 41% Loosely correlated | -0.68% | ||
| SANA - ACIU | 36% Loosely correlated | +3.42% | ||
| FDMT - ACIU | 36% Loosely correlated | -1.16% | ||
| ALEC - ACIU | 36% Loosely correlated | -0.44% | ||
| KURA - ACIU | 35% Loosely correlated | -1.49% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PBSE | 31.53 | -0.03 | -0.10% |
| PGIM S&P 500 Buffer 20 ETF - September (PBSE) | |||
| TCAN | 17.10 | -0.02 | -0.10% |
| 21Shares Canton Network ETF (TCAN) | |||
| RAA | 30.26 | -0.07 | -0.24% |
| SMI 3Fourteen REAL Asset Allocation ETF (RAA) | |||
| GPIQ | 56.07 | -0.73 | -1.29% |
| Goldman Sachs Nasdaq-100 Premium Income ETF (GPIQ) | |||
| GSOL | 7.56 | -0.26 | -3.32% |
| Grayscale Solana Staking ETF | |||